The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease
Yıl: 2023 Cilt: 4 Sayı: 1 Sayfa Aralığı: 1 - 2 Metin Dili: İngilizce DOI: 10.14744/hf.2023.2023.0004 İndeks Tarihi: 04-06-2023
The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editoryal Erişim Türü: Erişime Açık
- 1. Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdom Radiol (NY) 2020;45(11):3444- 3462. [CrossRef]
- 2. Serai SD, Obuchowski NA, Venkatesh SK, Sirlin CB, Miller FH, Ashton E, et al. Repeatability of MR elastography of liver: A meta-analysis. Radiology 2017;285(1):92-100. [CrossRef]
- 3. Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, et al. Mag- netic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual partic- ipant data pooled analysis. Eur Radiol 2016;26(5):1431-1440. [CrossRef]
- 4. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, et al. Diagnostic performance of magnetic resonance elastography in staging liv- er fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 2015;13(3):440-451.e6. [CrossRef]
- 5. Bi J, Liu L, Qin T. Comparison of magnetic resonance elastography and transient elastography in the diagnosis of hepatic fibrosis: a systematic re- view and meta-analysis. Ann Palliat Med 2021;10(8):8692-8700. [CrossRef]
- 6. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early de- tection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011;259(3):749-756. [CrossRef]
- 7. Tamaki N, Imajo K, Sharpton S, Jung J, Kawamura N, Yoneda M, et al. Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspar - tate aminotransferase in detection of candidates for pharmacological treat- ment of NASH-related fibrosis. Hepatology 2022;75(3):661-672. [CrossRef]
- 8. Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology 2017;66(5):1486-1501. [CrossRef]
- 9. Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastog - raphy. Radiology 2013;268(2):411-419. [CrossRef]
- 10. Ajmera VH, Liu A, Singh S, Yachoa G, Ramey M, Bhargava M, et al. Clinical utility of an increase in magnetic resonance elastography in pre- dicting fibrosis progression in nonalcoholic fatty liver disease. Hepatology 2020;71(3):849-860. [CrossRef]
- 11. Gidener T, Ahmed OT, Larson JJ, Mara KC, Therneau TM, Venkatesh SK, et al. Liver stiffness by magnetic resonance elastography predicts future cir- rhosis, decompensation, and death in NAFLD. Clin Gastroenterol Hepatol 2021;19(9):1915-1924.e6. [CrossRef]
- 12. Ajmera V, Kim BK, Yang K, Majzoub AM, Nayfeh T, Tamaki N, et al. Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related outcomes in nonalcoholic fatty liver disease: A system- atic review and meta-analysis of individual participants. Gastroenterology 2022;163(4):1079-1089.e5. [CrossRef]
| APA | Idilman I, Karcaaltincaba M (2023). The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. , 1 - 2. 10.14744/hf.2023.2023.0004 |
| Chicago | Idilman Ilkay,Karcaaltincaba Musturay The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. (2023): 1 - 2. 10.14744/hf.2023.2023.0004 |
| MLA | Idilman Ilkay,Karcaaltincaba Musturay The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. , 2023, ss.1 - 2. 10.14744/hf.2023.2023.0004 |
| AMA | Idilman I,Karcaaltincaba M The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. . 2023; 1 - 2. 10.14744/hf.2023.2023.0004 |
| Vancouver | Idilman I,Karcaaltincaba M The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. . 2023; 1 - 2. 10.14744/hf.2023.2023.0004 |
| IEEE | Idilman I,Karcaaltincaba M "The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease." , ss.1 - 2, 2023. 10.14744/hf.2023.2023.0004 |
| ISNAD | Idilman, Ilkay - Karcaaltincaba, Musturay. "The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease". (2023), 1-2. https://doi.org/10.14744/hf.2023.2023.0004 |
| APA | Idilman I, Karcaaltincaba M (2023). The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. Hepatology forum, 4(1), 1 - 2. 10.14744/hf.2023.2023.0004 |
| Chicago | Idilman Ilkay,Karcaaltincaba Musturay The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. Hepatology forum 4, no.1 (2023): 1 - 2. 10.14744/hf.2023.2023.0004 |
| MLA | Idilman Ilkay,Karcaaltincaba Musturay The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. Hepatology forum, vol.4, no.1, 2023, ss.1 - 2. 10.14744/hf.2023.2023.0004 |
| AMA | Idilman I,Karcaaltincaba M The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. Hepatology forum. 2023; 4(1): 1 - 2. 10.14744/hf.2023.2023.0004 |
| Vancouver | Idilman I,Karcaaltincaba M The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. Hepatology forum. 2023; 4(1): 1 - 2. 10.14744/hf.2023.2023.0004 |
| IEEE | Idilman I,Karcaaltincaba M "The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease." Hepatology forum, 4, ss.1 - 2, 2023. 10.14744/hf.2023.2023.0004 |
| ISNAD | Idilman, Ilkay - Karcaaltincaba, Musturay. "The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease". Hepatology forum 4/1 (2023), 1-2. https://doi.org/10.14744/hf.2023.2023.0004 |
